Skip to main content
Caplight Logo









Myria Biosciences

Myria Biosciences

Private
BaselHealthcare & Life Scienceshttps://www.myria.bio/

Last Round

Pre Seed

Jun 20, 2024

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Myria Biosciences is a biotechnology company that develops therapeutic molecules using its synthetic intelligence platform to transform drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

drug discovery platformAI drug discoverysynthetic biologytech-biogenerative biologynatural product discoveryundruggable targetsAI-native biotechdrug discovery engineGEMMS platformhigh-throughput screeningSynBiobiopharmaceuticalsdrug candidate pipelinepharma partnerships

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Myria Biosciences Comparables

Compare Myria Biosciences with similar companies based on industry and business-model similarity.

Myria Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Biomia
87%
Generare
84%
Protuoso Biosciences
82%

Myria Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedJun 20, 2024

Key People

Founding team and executive leadership

Steven Schmitt

CEO, Cofounder

Founding Team

Myria Biosciences Investors

Notable investors and investment history

Myria Biosciences investors
InvestorRounds
Capital Blue PartnersPre Seed
Rockmount Seed InvestmentsPre Seed
The Creator FundPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 67% MoM.

  • Jan 5, 2026

    Monthly visitors increased 46% MoM.

Myria Biosciences Filings

Explore SEC and related filing metadata, where available.

Myria Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Myria Biosciences's valuation, stock price, and market status.

Is Myria Biosciences a public or private company?

Myria Biosciences is a private company.

What is the current stock price of Myria Biosciences?

Myria Biosciences is a private company with no public stock price. No recent secondary market data is available.

How much is Myria Biosciences worth (valuation)?

Valuation information for Myria Biosciences is not publicly available.

Can I buy Myria Biosciences stock?

Myria Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Myria Biosciences's last funding round?

Myria Biosciences's most recent funding round was Pre Seed on June 20, 2024.

Who are the main investors in Myria Biosciences?

Key investors in Myria Biosciences include The Creator Fund.

Will Myria Biosciences IPO soon?

No public IPO plans have been announced for Myria Biosciences.

How can I track Myria Biosciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Myria Biosciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBasel
Employee Range7
Year Founded2022
Last FundingJun 20, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?